Immunogenic properties of nickel-doped maghemite nanoparticles and the implication for cancer immunotherapy DOI Creative Commons
Lenka Rajsiglová, Michal Babič,

Kateřina Krausová

и другие.

Journal of Immunotoxicology, Год журнала: 2024, Номер 21(1)

Опубликована: Ноя. 1, 2024

Nanoparticles are commonly used in diagnostics and therapy. They also increasingly being implemented cancer immunotherapy because of their ability to deliver drugs modulate the immune system. However, effect nanoparticles on cells involved anti-tumor response is not well understood. The study reported here showed that nickel-doped maghemite (FN NP) differentially cytotoxic cultured mouse human cell lines, causing death without negatively impacting subsequent anticancer response. It found FN NP induced colorectal line CT26 prostate PC-3, but LNCaP. did affect phenotype responsivity isolated peritoneal macrophages, or ex vivo-generated bone marrow-derived, monocyte-derived dendritic cells. Additionally, prevent from stimulating lymphocytes enriching cultures with cell-reactive T-cells. In conclusion, this shows could be a valuable platform for targeting immunosuppressive effects

Язык: Английский

HDAC6 inhibition through WT161 synergizes with temozolomide, induces apoptosis, reduces cell motility, and decreases β-catenin levels in glioblastoma cells DOI

Leilane Sales Oliveira,

João Marcos Oliveira‐Silva, Hebréia O. Almeida-Souza

и другие.

Investigational New Drugs, Год журнала: 2025, Номер unknown

Опубликована: Фев. 15, 2025

Язык: Английский

Процитировано

0

Inhibitory Effects of Paclitaxel-Loaded Iron Oxide Nanoparticles on Non-Small Cell Lung Cancer by Enhancing Autophagy-Dependent Ferroptosis and Apoptosis Pathways DOI Creative Commons

Ruijuan Deng,

Guanghong Liang,

Wenqing Chen

и другие.

Cancer Management and Research, Год журнала: 2025, Номер Volume 17, С. 541 - 555

Опубликована: Март 1, 2025

Background: Iron oxide nanoparticles coated with paclitaxel (IONP@PTX) are frequently applied to various tumor types. However, inhibitory effect and possible mechanism of IONP@ PTX on non-small-cell lung cancer (NSCLC) remain unclear. Objective: This work aimed assess effects potential mechanisms IONP@PTX A549 cells further explore the nanomedicine delivery systems for applications in therapies. Methods: Morphology features qualities were directly assessed. After treatment either or IONP@PTX, cell viability apoptosis separately detected by CCK‑8 assay flow cytometry. In addition, intracellular iron ion, lipid peroxidation (LPD) reactive oxygen species (ROS) identified using an colorimetric kit, DCFH-DA C11-BODIPY fluorescent probe, respectively. Moreover, expression levels autophagy-, ferroptosis-, apoptosis-related proteins measured Western blot. Results: The synthesized had a core particle size about 10 nm hydrated 31.01± 2.47 nm. comparison PTX, stronger anti-tumor cells, considerably higher ROS, LPD, total ion concentration ( P < 0.05). Likewise, markedly reduced GPX4, FTH, SLC7A11 whereas obviously increased LC3II/I ACSL4 Furthermore, both could be evidently reversed additional 3-methyladenine (3-MA) ferrostatin-1. Interestingly, rates together level pro-apoptotic protein Cleaved caspase-3, significantly group than those control groups Conclusion: inhibits proliferation human enhancing autophagy-dependent ferroptosis pathways. Keywords: paclitaxel, ferroptosis, autophagy,

Язык: Английский

Процитировано

0

Radiosensitizing effects of heparinized magnetic iron oxide nanoparticles in colon cancer DOI Open Access
Maria V. Shestovskaya, Anna L. Luss, Bezborodova Si

и другие.

Biomedicine & Pharmacotherapy, Год журнала: 2024, Номер 175, С. 116668 - 116668

Опубликована: Май 2, 2024

The combination of radiation treatment and chemotherapy is currently the standard for management cancer patients. However, safe doses do not often provide effective therapy, then pre-treated patients are forced to repeat with already increased tumor resistance drugs irradiation. One solutions we suggest improve primary course via enhancing radiosensitivity tumors by magnetic-guided iron oxide nanoparticles (magnetite). We obtained spherical heparinized (hIONPs, ∼20 nm), characterized it TEM, Infrared spectroscopy DLS. Then hIONPs cytotoxicity was assessed colon cells (XTT assay) cellular uptake analyzed X-ray fluorescence. Combination ionizing (IR) in vitro caused an increase G2/M arrest cell cycle, mitotic errors decrease survival (compared samples exposed IR separately). promising results were shown CT26-grafted BALB/C mice: intravenously administrated showed 20,8% T/C ratio (related non-treated mice), while single had no significant growth (72,4%). Non-guided magnets 57,9% T/C. This indicates that ultra-small size biocompatible molecule key successful nano-drug design, each case, delivery technologies need be improved when transferred vivo model.

Язык: Английский

Процитировано

3

Ferroptosis: emerging roles in lung cancer and potential implications in biological compounds DOI Creative Commons

Qiuran Liang,

Yuehui Wang,

Yili Li

и другие.

Frontiers in Pharmacology, Год журнала: 2024, Номер 15

Опубликована: Май 9, 2024

Lung cancer has high metastasis and drug resistance. The prognosis of lung patients is poor the patients’ survival chances are easily neglected. Ferroptosis a programmed cell death proposed in 2012, which differs from apoptosis, necrosis autophagy. novel type regulated driven by iron-dependent lipid peroxidation subsequent plasma membrane ruptures. It broad prospects field tumor disease treatment. At present, multiple studies have shown that biological compounds can induce ferroptosis cells, exhibits significant anti-cancer effects, they advantages safety, minimal side less possibility to In this review, we summarize used for treatment focusing on its mechanism. addition, systematically review current research status combining nanotechnology with treatment, shed new light targeting pathways applying compounds-based therapies.

Язык: Английский

Процитировано

3

Nano-inducer of ferroptosis for targeted chemotherapy of human triple negative breast carcinoma DOI
Neena G. Shetake, Sourav Das, Amit Kumar

и другие.

Biomaterials Advances, Год журнала: 2024, Номер 161, С. 213868 - 213868

Опубликована: Апрель 21, 2024

Язык: Английский

Процитировано

2

Ferroptosis-inducing nanocomposite hydrogels: A multimodal platform for enhanced cancer therapeutics DOI
Shanhe Li, Yuqing Qian, Xuan Zhang

и другие.

Chemical Engineering Journal, Год журнала: 2024, Номер 500, С. 157451 - 157451

Опубликована: Ноя. 1, 2024

Язык: Английский

Процитировано

1

Immunogenic properties of nickel-doped maghemite nanoparticles and the implication for cancer immunotherapy DOI Creative Commons
Lenka Rajsiglová, Michal Babič,

Kateřina Krausová

и другие.

Journal of Immunotoxicology, Год журнала: 2024, Номер 21(1)

Опубликована: Ноя. 1, 2024

Nanoparticles are commonly used in diagnostics and therapy. They also increasingly being implemented cancer immunotherapy because of their ability to deliver drugs modulate the immune system. However, effect nanoparticles on cells involved anti-tumor response is not well understood. The study reported here showed that nickel-doped maghemite (FN NP) differentially cytotoxic cultured mouse human cell lines, causing death without negatively impacting subsequent anticancer response. It found FN NP induced colorectal line CT26 prostate PC-3, but LNCaP. did affect phenotype responsivity isolated peritoneal macrophages, or ex vivo-generated bone marrow-derived, monocyte-derived dendritic cells. Additionally, prevent from stimulating lymphocytes enriching cultures with cell-reactive T-cells. In conclusion, this shows could be a valuable platform for targeting immunosuppressive effects

Язык: Английский

Процитировано

0